F. Ponticelli

Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.

S. Ferrari, P. Picci, L. Zanella, 2007, Cancer letters.

Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.

P. Picci, F. Bertoni, M. Alberghini, 2004, Histology and histopathology.

Alpha-tocopheryl succinate induces cytostasis and apoptosis in osteosarcoma cells: the role of E2F1.

P. Picci, J. Neuzil, M. Benassi, 2005, Biochemical and biophysical research communications.

Identification of markers of possible prognostic value in 57 giant cell tumors of bone.

P. Picci, F. Bertoni, M. Serra, 2003, Oncology reports.

Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone.

P. Picci, F. Bertoni, A. Balladelli, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas.

E. Pignotti, P. Picci, P. Bacchini, 2007, Histology and histopathology.

Molecular alterations of monophasic synovial sarcoma: loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity.

P. Picci, L. Zanella, M. Alberghini, 2006, Histology and histopathology.

Activation of metalloproteinases-2 and -9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness.

P. Picci, A. Balladelli, M. Benassi, 2004, Anticancer research.

Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcomaFindings in 42 patients followed for 1–16 years

P. Picci, F. Bertoni, A. Balladelli, 2004, Acta orthopaedica Scandinavica.

Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas.

P. Picci, L. Zanella, M. Benassi, 2003, Histology and histopathology.